IAP inhibitors (HQL Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameIAP inhibitors (HQL Pharmaceuticals)
Drug Alias NameSMAC mimetics (HQL Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiablo homolog, mitochondrial stimulants
TargetsDiablo homolog, mitochondrial
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHQL Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHQL Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A